低用量水和物阻害剤（LDHI）の世界市場レポート2020

• 英文タイトル：Global Low-Dosage Hydrate Inhibitors (LDHIs) Sales Market Report 2020

• レポートコード：QY20ST-00500 • 出版社/出版日：QYResearch / 2020年9月15日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、131ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：化学・材料

• 販売価格（消費税別）

Single User	￥560,000 (USD4,000)	▷ お問い合わせ
Multi User	￥840,000 (USD6,000)	▷ お問い合わせ
Enterprise License	￥1,120,000 (USD8,000)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査レポートでは、世界の低用量水和物阻害剤（LDHI）市場について種類別（抗凝集（AA）阻害剤、キネティックハイドレート阻害剤（KHI））、用途別（オンショア、オフショア）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・低用量水和物阻害剤（LDHI）市場の概要 ・世界の主要地域別低用量水和物阻害剤（LDHI）市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の低用量水和物阻害剤（LDHI）市場規模2015-2026：種類別（抗凝集（AA）阻害剤、キネティックハイドレート阻害剤（KHI）） ・世界の低用量水和物阻害剤（LDHI）市場規模2015-2026：用途別（オンショア、オフショア） ・低用量水和物阻害剤（LDHI）の北米市場規模2015-2020 ・低用量水和物阻害剤（LDHI）のヨーロッパ市場規模2015-2020 ・低用量水和物阻害剤（LDHI）の中国市場規模2015-2020 ・低用量水和物阻害剤（LDHI）の日本市場規模2015-2020 ・低用量水和物阻害剤（LDHI）の東南アジア市場規模2015-2020 ・低用量水和物阻害剤（LDHI）のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・低用量水和物阻害剤（LDHI）の製造コスト分析 ・販売チャネル、流通業者、顧客 ・低用量水和物阻害剤（LDHI）の市場動向・機会・課題 ・調査の結論

A recently published report by QY Research titled Global Low-Dosage Hydrate Inhibitors (LDHIs) Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Low-Dosage Hydrate Inhibitors (LDHIs) market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Hydrate inhibitors are used in order to prevent the formation of gas hydrates at lower temperature and high pressure conditions. There are two types of hydrate inhibitors – thermodynamic inhibitors and low dosage hydrate inhibitors. Low dosage hydrate inhibitors are of two types – anti-agglomerate (AA) inhibitors and kinetic hydrate inhibitors (KHIs). They are mainly utilized in onshore and offshore operations in the oil and gas industry.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Low-Dosage Hydrate Inhibitors (LDHIs) market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Low-Dosage Hydrate Inhibitors (LDHIs) industry.
Based on our recent survey, we have several different scenarios about the Low-Dosage Hydrate Inhibitors (LDHIs) YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Low-Dosage Hydrate Inhibitors (LDHIs) will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Low-Dosage Hydrate Inhibitors (LDHIs) market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Low-Dosage Hydrate Inhibitors (LDHIs) market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Low-Dosage Hydrate Inhibitors (LDHIs) market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Low-Dosage Hydrate Inhibitors (LDHIs) market. The report also includes nautical information, where it shows Low-Dosage Hydrate Inhibitors (LDHIs) market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Low-Dosage Hydrate Inhibitors (LDHIs) market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Low-Dosage Hydrate Inhibitors (LDHIs) market.
Geographical Analysis:
Based on region, the global Low-Dosage Hydrate Inhibitors (LDHIs) market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Low-Dosage Hydrate Inhibitors (LDHIs) market are
Schlumberger
BHGE
Halliburton
Ecolab
BASF
Arkema
Ashland
Clariant
Segment by Type
Anti-Agglomerate (AA) Inhibitors
Kinetic Hydrate Inhibitors (KHI)
Segment by Application
Onshore
Offshore
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Low-Dosage Hydrate Inhibitors (LDHIs) market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Low-Dosage Hydrate Inhibitors (LDHIs) market.
• The market share of the global Low-Dosage Hydrate Inhibitors (LDHIs) market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Low-Dosage Hydrate Inhibitors (LDHIs) market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Low-Dosage Hydrate Inhibitors (LDHIs) market.

レポート目次

---

1 Low-Dosage Hydrate Inhibitors (LDHIs) Market Overview
1.1 Low-Dosage Hydrate Inhibitors (LDHIs) Product Scope
1.2 Low-Dosage Hydrate Inhibitors (LDHIs) Segment by Type
1.2.1 Global Low-Dosage Hydrate Inhibitors (LDHIs) Sales by Type (2020-2026)
1.2.2 Anti-Agglomerate (AA) Inhibitors
1.2.3 Kinetic Hydrate Inhibitors (KHI)
1.3 Low-Dosage Hydrate Inhibitors (LDHIs) Segment by Application
1.3.1 Global Low-Dosage Hydrate Inhibitors (LDHIs) Sales Comparison by Application (2020-2026)
1.3.2 Onshore
1.3.3 Offshore
1.4 Low-Dosage Hydrate Inhibitors (LDHIs) Market Estimates and Forecasts (2015-2026)
1.4.1 Global Low-Dosage Hydrate Inhibitors (LDHIs) Sales Growth Rate (2015-2026)
1.4.2 Global Low-Dosage Hydrate Inhibitors (LDHIs) Revenue and Growth Rate (2015-2026)
1.4.3 Global Low-Dosage Hydrate Inhibitors (LDHIs) Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Low-Dosage Hydrate Inhibitors (LDHIs) Industry Impact
1.5.1 How the Covid-19 is Affecting the Low-Dosage Hydrate Inhibitors (LDHIs) Industry
1.5.1.1 Low-Dosage Hydrate Inhibitors (LDHIs) Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Low-Dosage Hydrate Inhibitors (LDHIs) Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Low-Dosage Hydrate Inhibitors (LDHIs) Players to Combat Covid-19 Impact

2 Low-Dosage Hydrate Inhibitors (LDHIs) Estimate and Forecast by Region
2.1 Global Low-Dosage Hydrate Inhibitors (LDHIs) Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Low-Dosage Hydrate Inhibitors (LDHIs) Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Low-Dosage Hydrate Inhibitors (LDHIs) Sales Market Share by Region (2015-2020)
2.2.2 Global Low-Dosage Hydrate Inhibitors (LDHIs) Revenue Market Share by Region (2015-2020)
2.3 Global Low-Dosage Hydrate Inhibitors (LDHIs) Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Low-Dosage Hydrate Inhibitors (LDHIs) Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Low-Dosage Hydrate Inhibitors (LDHIs) Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Low-Dosage Hydrate Inhibitors (LDHIs) Estimates and Projections (2015-2026)
2.4.2 Europe Low-Dosage Hydrate Inhibitors (LDHIs) Estimates and Projections (2015-2026)
2.4.3 China Low-Dosage Hydrate Inhibitors (LDHIs) Estimates and Projections (2015-2026)
2.4.4 Japan Low-Dosage Hydrate Inhibitors (LDHIs) Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Low-Dosage Hydrate Inhibitors (LDHIs) Estimates and Projections (2015-2026)
2.4.6 India Low-Dosage Hydrate Inhibitors (LDHIs) Estimates and Projections (2015-2026)
3 Global Low-Dosage Hydrate Inhibitors (LDHIs) Competition Landscape by Players
3.1 Global Top Low-Dosage Hydrate Inhibitors (LDHIs) Players by Sales (2015-2020)
3.2 Global Top Low-Dosage Hydrate Inhibitors (LDHIs) Players by Revenue (2015-2020)
3.3 Global Low-Dosage Hydrate Inhibitors (LDHIs) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Low-Dosage Hydrate Inhibitors (LDHIs) as of 2019)
3.4 Global Low-Dosage Hydrate Inhibitors (LDHIs) Average Price by Company (2015-2020)
3.5 Manufacturers Low-Dosage Hydrate Inhibitors (LDHIs) Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Low-Dosage Hydrate Inhibitors (LDHIs) Players (Opinion Leaders)
4 Global Low-Dosage Hydrate Inhibitors (LDHIs) Market Size by Type
4.1 Global Low-Dosage Hydrate Inhibitors (LDHIs) Historic Market Review by Type (2015-2020)
4.1.1 Global Low-Dosage Hydrate Inhibitors (LDHIs) Sales Market Share by Type (2015-2020)
4.1.2 Global Low-Dosage Hydrate Inhibitors (LDHIs) Revenue Market Share by Type (2015-2020)
4.1.3 Global Low-Dosage Hydrate Inhibitors (LDHIs) Price by Type (2014-2020)
4.2 Global Low-Dosage Hydrate Inhibitors (LDHIs) Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Low-Dosage Hydrate Inhibitors (LDHIs) Sales Forecast by Type (2021-2026)
4.2.2 Global Low-Dosage Hydrate Inhibitors (LDHIs) Revenue Forecast by Type (2021-2026)
4.2.3 Global Low-Dosage Hydrate Inhibitors (LDHIs) Price Forecast by Type (2021-2026)
5 Global Low-Dosage Hydrate Inhibitors (LDHIs) Market Size by Application
5.1 Global Low-Dosage Hydrate Inhibitors (LDHIs) Historic Market Review by Application (2015-2020)
5.1.1 Global Low-Dosage Hydrate Inhibitors (LDHIs) Sales Market Share by Application (2015-2020)
5.1.2 Global Low-Dosage Hydrate Inhibitors (LDHIs) Revenue Market Share by Application (2015-2020)
5.1.3 Global Low-Dosage Hydrate Inhibitors (LDHIs) Price by Application (2015-2020)
5.2 Global Low-Dosage Hydrate Inhibitors (LDHIs) Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Low-Dosage Hydrate Inhibitors (LDHIs) Sales Forecast by Application (2021-2026)
5.2.2 Global Low-Dosage Hydrate Inhibitors (LDHIs) Revenue Forecast by Application (2021-2026)
5.2.3 Global Low-Dosage Hydrate Inhibitors (LDHIs) Price Forecast by Application (2021-2026)

3 North America Low-Dosage Hydrate Inhibitors (LDHIs) Market Facts & Figures
3.2 North America Low-Dosage Hydrate Inhibitors (LDHIs) Sales Market Share by Company (2015-2020)
3.3 North America Low-Dosage Hydrate Inhibitors (LDHIs) Sales Market Share by Type (2015-2020)
3.4 North America Low-Dosage Hydrate Inhibitors (LDHIs) Sales Market Share by Application (2015-2020)

4 Europe Low-Dosage Hydrate Inhibitors (LDHIs) Market Facts & Figures
4.2 Europe Low-Dosage Hydrate Inhibitors (LDHIs) Sales Market Share by Company (2015-2020)
4.3 Europe Low-Dosage Hydrate Inhibitors (LDHIs) Sales Market Share by Type (2015-2020)
4.4 Europe Low-Dosage Hydrate Inhibitors (LDHIs) Sales Market Share by Application (2015-2020)

5 China Low-Dosage Hydrate Inhibitors (LDHIs) Market Facts & Figures
5.2 China Low-Dosage Hydrate Inhibitors (LDHIs) Sales Market Share by Company (2015-2020)
5.3 China Low-Dosage Hydrate Inhibitors (LDHIs) Sales Market Share by Type (2015-2020)
5.4 China Low-Dosage Hydrate Inhibitors (LDHIs) Sales Market Share by Application (2015-2020)

6 Japan Low-Dosage Hydrate Inhibitors (LDHIs) Market Facts & Figures
6.2 Japan Low-Dosage Hydrate Inhibitors (LDHIs) Sales Market Share by Company (2015-2020)
6.3 Japan Low-Dosage Hydrate Inhibitors (LDHIs) Sales Market Share by Type (2015-2020)
6.4 Japan Low-Dosage Hydrate Inhibitors (LDHIs) Sales Market Share by Application (2015-2020)

7 Southeast Asia Low-Dosage Hydrate Inhibitors (LDHIs) Market Facts & Figures
7.2 Southeast Asia Low-Dosage Hydrate Inhibitors (LDHIs) Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Low-Dosage Hydrate Inhibitors (LDHIs) Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Low-Dosage Hydrate Inhibitors (LDHIs) Sales Market Share by Application (2015-2020)

8 India Low-Dosage Hydrate Inhibitors (LDHIs) Market Facts & Figures
8.2 India Low-Dosage Hydrate Inhibitors (LDHIs) Sales Market Share by Company (2015-2020)
8.3 India Low-Dosage Hydrate Inhibitors (LDHIs) Sales Market Share by Type (2015-2020)
8.4 India Low-Dosage Hydrate Inhibitors (LDHIs) Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Low-Dosage Hydrate Inhibitors (LDHIs) Business
12.1 Schlumberger
12.1.1 Schlumberger Low-Dosage Hydrate Inhibitors (LDHIs) Corporation Information
12.1.2 Schlumberger Low-Dosage Hydrate Inhibitors (LDHIs) Business Overview and Total Revenue
12.1.3 Schlumberger Low-Dosage Hydrate Inhibitors (LDHIs) Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Schlumberger Low-Dosage Hydrate Inhibitors (LDHIs) Products Offered
12.1.5 Schlumberger Recent Development
12.2 BHGE
12.2.1 BHGE Low-Dosage Hydrate Inhibitors (LDHIs) Corporation Information
12.2.2 BHGE Low-Dosage Hydrate Inhibitors (LDHIs) Business Overview and Total Revenue
12.2.3 BHGE Low-Dosage Hydrate Inhibitors (LDHIs) Sales, Revenue and Gross Margin (2015-2020)
12.2.4 BHGE Low-Dosage Hydrate Inhibitors (LDHIs) Products Offered
12.2.5 BHGE Recent Development
12.3 Halliburton
12.3.1 Halliburton Low-Dosage Hydrate Inhibitors (LDHIs) Corporation Information
12.3.2 Halliburton Low-Dosage Hydrate Inhibitors (LDHIs) Business Overview and Total Revenue
12.3.3 Halliburton Low-Dosage Hydrate Inhibitors (LDHIs) Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Halliburton Low-Dosage Hydrate Inhibitors (LDHIs) Products Offered
12.3.5 Halliburton Recent Development
12.4 Ecolab
12.4.1 Ecolab Low-Dosage Hydrate Inhibitors (LDHIs) Corporation Information
12.4.2 Ecolab Low-Dosage Hydrate Inhibitors (LDHIs) Business Overview and Total Revenue
12.4.3 Ecolab Low-Dosage Hydrate Inhibitors (LDHIs) Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Ecolab Low-Dosage Hydrate Inhibitors (LDHIs) Products Offered
12.4.5 Ecolab Recent Development
12.5 BASF
12.5.1 BASF Low-Dosage Hydrate Inhibitors (LDHIs) Corporation Information
12.5.2 BASF Low-Dosage Hydrate Inhibitors (LDHIs) Business Overview and Total Revenue
12.5.3 BASF Low-Dosage Hydrate Inhibitors (LDHIs) Sales, Revenue and Gross Margin (2015-2020)
12.5.4 BASF Low-Dosage Hydrate Inhibitors (LDHIs) Products Offered
12.5.5 BASF Recent Development
12.6 Arkema
12.6.1 Arkema Low-Dosage Hydrate Inhibitors (LDHIs) Corporation Information
12.6.2 Arkema Low-Dosage Hydrate Inhibitors (LDHIs) Business Overview and Total Revenue
12.6.3 Arkema Low-Dosage Hydrate Inhibitors (LDHIs) Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Arkema Low-Dosage Hydrate Inhibitors (LDHIs) Products Offered
12.6.5 Arkema Recent Development
12.7 Ashland
12.7.1 Ashland Low-Dosage Hydrate Inhibitors (LDHIs) Corporation Information
12.7.2 Ashland Low-Dosage Hydrate Inhibitors (LDHIs) Business Overview and Total Revenue
12.7.3 Ashland Low-Dosage Hydrate Inhibitors (LDHIs) Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Ashland Low-Dosage Hydrate Inhibitors (LDHIs) Products Offered
12.7.5 Ashland Recent Development
12.8 Clariant
12.8.1 Clariant Low-Dosage Hydrate Inhibitors (LDHIs) Corporation Information
12.8.2 Clariant Low-Dosage Hydrate Inhibitors (LDHIs) Business Overview and Total Revenue
12.8.3 Clariant Low-Dosage Hydrate Inhibitors (LDHIs) Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Clariant Low-Dosage Hydrate Inhibitors (LDHIs) Products Offered
12.8.5 Clariant Recent Development

13 Low-Dosage Hydrate Inhibitors (LDHIs) Manufacturing Cost Analysis
13.1 Low-Dosage Hydrate Inhibitors (LDHIs) Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Low-Dosage Hydrate Inhibitors (LDHIs)
13.4 Low-Dosage Hydrate Inhibitors (LDHIs) Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Low-Dosage Hydrate Inhibitors (LDHIs) Distributors List
14.3 Low-Dosage Hydrate Inhibitors (LDHIs) Customers

15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables
Table 1. Global Low-Dosage Hydrate Inhibitors (LDHIs) Sales (MT) Growth Rate by Type (2020-2026)
Table 2. Global Low-Dosage Hydrate Inhibitors (LDHIs) Sales (MT) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Low-Dosage Hydrate Inhibitors (LDHIs) Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Low-Dosage Hydrate Inhibitors (LDHIs) Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Low-Dosage Hydrate Inhibitors (LDHIs) Players to Combat Covid-19 Impact
Table 8. Global Market Low-Dosage Hydrate Inhibitors (LDHIs) Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Low-Dosage Hydrate Inhibitors (LDHIs) Sales (MT) by Region (2015-2020)
Table 10. Global Low-Dosage Hydrate Inhibitors (LDHIs) Sales Market Share by Region (2015-2020)
Table 11. Global Low-Dosage Hydrate Inhibitors (LDHIs) Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Low-Dosage Hydrate Inhibitors (LDHIs) Revenue Share by Region (2015-2020)
Table 13. Global Low-Dosage Hydrate Inhibitors (LDHIs) Sales (MT) Forecast by Region (2021-2026)
Table 14. Global Low-Dosage Hydrate Inhibitors (LDHIs) Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Low-Dosage Hydrate Inhibitors (LDHIs) Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Low-Dosage Hydrate Inhibitors (LDHIs) Revenue Share Forecast by Region (2021-2026)
Table 17. Global Low-Dosage Hydrate Inhibitors (LDHIs) (MT) of Key Companies (2015-2020)
Table 18. Global Low-Dosage Hydrate Inhibitors (LDHIs) Sales Share by Company (2015-2020)
Table 19. Global Low-Dosage Hydrate Inhibitors (LDHIs) Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Low-Dosage Hydrate Inhibitors (LDHIs) Revenue Share by Company (2015-2020)
Table 21. Global Low-Dosage Hydrate Inhibitors (LDHIs) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Low-Dosage Hydrate Inhibitors (LDHIs) as of 2019)
Table 22. Global Low-Dosage Hydrate Inhibitors (LDHIs) Average Price (USD/Kg) of Key Company (2015-2020)
Table 23. Manufacturers Low-Dosage Hydrate Inhibitors (LDHIs) Manufacturing Sites and Area Served
Table 24. Manufacturers Low-Dosage Hydrate Inhibitors (LDHIs) Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Low-Dosage Hydrate Inhibitors (LDHIs) Players
Table 27. Global Low-Dosage Hydrate Inhibitors (LDHIs) Sales (MT) by Type (2015-2020)
Table 28. Global Low-Dosage Hydrate Inhibitors (LDHIs) Sales Share by Type (2015-2020)
Table 29. Global Low-Dosage Hydrate Inhibitors (LDHIs) Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Low-Dosage Hydrate Inhibitors (LDHIs) Price (MT) by Type (2015-2020)
Table 31. Global Low-Dosage Hydrate Inhibitors (LDHIs) Sales Share by Type (2021-2026)
Table 32. Global Low-Dosage Hydrate Inhibitors (LDHIs) Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Low-Dosage Hydrate Inhibitors (LDHIs) Revenue Share by Type (2021-2026)
Table 34. Global Low-Dosage Hydrate Inhibitors (LDHIs) Price (MT) by Type (2021-2026)
Table 35. Global Low-Dosage Hydrate Inhibitors (LDHIs) Sales (MT) by Application (2015-2020)
Table 36. Global Low-Dosage Hydrate Inhibitors (LDHIs) Sales Share by Application (2015-2020)
Table 37. Global Low-Dosage Hydrate Inhibitors (LDHIs) Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Low-Dosage Hydrate Inhibitors (LDHIs) Price (MT) by Application (2015-2020)
Table 39. Global Low-Dosage Hydrate Inhibitors (LDHIs) Sales (MT) by Application (2021-2026)
Table 40. Global Low-Dosage Hydrate Inhibitors (LDHIs) Sales Share by Application (2021-2026)
Table 41. Global Low-Dosage Hydrate Inhibitors (LDHIs) Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Low-Dosage Hydrate Inhibitors (LDHIs) Revenue Share by Application (2021-2026)
Table 43. Global Low-Dosage Hydrate Inhibitors (LDHIs) Price (MT) by Application (2021-2026)
Table 44. United States Low-Dosage Hydrate Inhibitors (LDHIs) Sales (MT) by Company (2015-2020)
Table 45. United States Low-Dosage Hydrate Inhibitors (LDHIs) Sales Market Share by Company (2015-2020)
Table 46. United States Low-Dosage Hydrate Inhibitors (LDHIs) Sales (MT) by Type (2015-2020)
Table 47. United States Low-Dosage Hydrate Inhibitors (LDHIs) Sales Market Share by Type (2015-2020)
Table 48. United States Low-Dosage Hydrate Inhibitors (LDHIs) Sales (MT) by Application (2015-2020)
Table 49. United States Low-Dosage Hydrate Inhibitors (LDHIs) Sales Market Share by Application (2015-2020)
Table 50. Europe Low-Dosage Hydrate Inhibitors (LDHIs) Sales (MT) by Company (2015-2020)
Table 51. Europe Low-Dosage Hydrate Inhibitors (LDHIs) Sales Market Share by Company (2015-2020)
Table 52. Europe Low-Dosage Hydrate Inhibitors (LDHIs) Sales (MT) by Type (2015-2020)
Table 53. Europe Low-Dosage Hydrate Inhibitors (LDHIs) Sales Market Share by Type (2015-2020)
Table 54. Europe Low-Dosage Hydrate Inhibitors (LDHIs) Sales (MT) by Application (2015-2020)
Table 55. Europe Low-Dosage Hydrate Inhibitors (LDHIs) Sales Market Share by Type (2015-2020)
Table 56. China Low-Dosage Hydrate Inhibitors (LDHIs) Sales (MT) by Company (2015-2020)
Table 57. China Low-Dosage Hydrate Inhibitors (LDHIs) Sales Market Share by Company (2015-2020)
Table 58. China Low-Dosage Hydrate Inhibitors (LDHIs) Sales (MT) by Type (2015-2020)
Table 59. China Low-Dosage Hydrate Inhibitors (LDHIs) Sales Market Share by Type (2015-2020)
Table 60. China Low-Dosage Hydrate Inhibitors (LDHIs) Sales (MT) by Application (2015-2020)
Table 61. China Low-Dosage Hydrate Inhibitors (LDHIs) Sales Market Share by Application (2015-2020)
Table 62. Japan Low-Dosage Hydrate Inhibitors (LDHIs) Sales (MT) by Company (2015-2020)
Table 63. Japan Low-Dosage Hydrate Inhibitors (LDHIs) Sales Market Share by Company (2015-2020)
Table 64. Japan Low-Dosage Hydrate Inhibitors (LDHIs) Sales (MT) by Type (2015-2020)
Table 65. Japan Low-Dosage Hydrate Inhibitors (LDHIs) Sales Market Share by Type (2015-2020)
Table 66. Japan Low-Dosage Hydrate Inhibitors (LDHIs) Sales (MT) by Application (2015-2020)
Table 67. Japan Low-Dosage Hydrate Inhibitors (LDHIs) Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Low-Dosage Hydrate Inhibitors (LDHIs) Sales (MT) by Company (2015-2020)
Table 69. Southeast Asia Low-Dosage Hydrate Inhibitors (LDHIs) Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Low-Dosage Hydrate Inhibitors (LDHIs) Sales (MT) by Type (2015-2020)
Table 71. Southeast Asia Low-Dosage Hydrate Inhibitors (LDHIs) Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Low-Dosage Hydrate Inhibitors (LDHIs) Sales (MT) by Type (2015-2020)
Table 73. Southeast Asia Low-Dosage Hydrate Inhibitors (LDHIs) Sales Market Share by Application (2015-2020)
Table 74. India Low-Dosage Hydrate Inhibitors (LDHIs) Sales (MT) by Company (2015-2020)
Table 75. India Low-Dosage Hydrate Inhibitors (LDHIs) Sales Market Share by Company (2015-2020)
Table 76. India Low-Dosage Hydrate Inhibitors (LDHIs) Sales (MT) by Type (2015-2020)
Table 77. India Low-Dosage Hydrate Inhibitors (LDHIs) Sales Market Share by Type (2015-2020)
Table 78. India Low-Dosage Hydrate Inhibitors (LDHIs) Sales (MT) by Application (2015-2020)
Table 79. India Low-Dosage Hydrate Inhibitors (LDHIs) Sales Market Share by Application (2015-2020)
Table 80. Schlumberger Corporation Information
Table 81. Schlumberger Description and Business Overview
Table 82. Schlumberger Low-Dosage Hydrate Inhibitors (LDHIs) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 83. Schlumberger Low-Dosage Hydrate Inhibitors (LDHIs) Product
Table 84. Schlumberger Recent Development
Table 85. BHGE Corporation Information
Table 86. BHGE Description and Business Overview
Table 87. BHGE Low-Dosage Hydrate Inhibitors (LDHIs) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 88. BHGE Low-Dosage Hydrate Inhibitors (LDHIs) Product
Table 89. BHGE Recent Development
Table 90. Halliburton Corporation Information
Table 91. Halliburton Description and Business Overview
Table 92. Halliburton Low-Dosage Hydrate Inhibitors (LDHIs) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 93. Halliburton Low-Dosage Hydrate Inhibitors (LDHIs) Product
Table 94. Halliburton Recent Development
Table 95. Ecolab Corporation Information
Table 96. Ecolab Description and Business Overview
Table 97. Ecolab Low-Dosage Hydrate Inhibitors (LDHIs) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 98. Ecolab Low-Dosage Hydrate Inhibitors (LDHIs) Product
Table 99. Ecolab Recent Development
Table 100. BASF Corporation Information
Table 101. BASF Description and Business Overview
Table 102. BASF Low-Dosage Hydrate Inhibitors (LDHIs) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 103. BASF Low-Dosage Hydrate Inhibitors (LDHIs) Product
Table 104. BASF Recent Development
Table 105. Arkema Corporation Information
Table 106. Arkema Description and Business Overview
Table 107. Arkema Low-Dosage Hydrate Inhibitors (LDHIs) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 108. Arkema Low-Dosage Hydrate Inhibitors (LDHIs) Product
Table 109. Arkema Recent Development
Table 110. Ashland Corporation Information
Table 111. Ashland Description and Business Overview
Table 112. Ashland Low-Dosage Hydrate Inhibitors (LDHIs) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 113. Ashland Low-Dosage Hydrate Inhibitors (LDHIs) Product
Table 114. Ashland Recent Development
Table . Clariant Corporation Information
Table . Clariant Low-Dosage Hydrate Inhibitors (LDHIs) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table . Clariant Description and Business Overview
Table . Clariant Low-Dosage Hydrate Inhibitors (LDHIs) Product
Table . Clariant Recent Development
Table 120. Production Base and Market Concentration Rate of Raw Material
Table 121. Key Suppliers of Raw Materials
Table 122. Low-Dosage Hydrate Inhibitors (LDHIs) Distributors List
Table 123. Low-Dosage Hydrate Inhibitors (LDHIs) Customers List
Table 124. Market Key Trends
Table 125. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 126. Key Challenges
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Low-Dosage Hydrate Inhibitors (LDHIs) Product Picture
Figure 2. Global Low-Dosage Hydrate Inhibitors (LDHIs) Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Low-Dosage Hydrate Inhibitors (LDHIs) Market Share by Application in 2020 & 2026
Figure 6. Onshore Examples
Figure 7. Offshore Examples
Figure 8. Global Low-Dosage Hydrate Inhibitors (LDHIs) Sales (MT) Growth Rate (2015-2026)
Figure 9. Global Low-Dosage Hydrate Inhibitors (LDHIs) Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Low-Dosage Hydrate Inhibitors (LDHIs) Price Trends Growth Rate (2015-2026) (USD/Kg)
Figure 11. Global Low-Dosage Hydrate Inhibitors (LDHIs) Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Low-Dosage Hydrate Inhibitors (LDHIs) Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Low-Dosage Hydrate Inhibitors (LDHIs) Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Low-Dosage Hydrate Inhibitors (LDHIs) Sales (MT) Growth Rate (2015-2026)
Figure 15. Europe Low-Dosage Hydrate Inhibitors (LDHIs) Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Low-Dosage Hydrate Inhibitors (LDHIs) Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Low-Dosage Hydrate Inhibitors (LDHIs) Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Low-Dosage Hydrate Inhibitors (LDHIs) Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Low-Dosage Hydrate Inhibitors (LDHIs) Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Low-Dosage Hydrate Inhibitors (LDHIs) Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Low-Dosage Hydrate Inhibitors (LDHIs) Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Low-Dosage Hydrate Inhibitors (LDHIs) Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Low-Dosage Hydrate Inhibitors (LDHIs) Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Low-Dosage Hydrate Inhibitors (LDHIs) Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Low-Dosage Hydrate Inhibitors (LDHIs) Players Market Share by Revenue in Low-Dosage Hydrate Inhibitors (LDHIs) 2015 & 2019
Figure 26. Low-Dosage Hydrate Inhibitors (LDHIs) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Low-Dosage Hydrate Inhibitors (LDHIs) Revenue Share by Type (2015-2020)
Figure 28. Global Low-Dosage Hydrate Inhibitors (LDHIs) Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Low-Dosage Hydrate Inhibitors (LDHIs) Revenue Share by Application (2015-2020)
Figure 30. Global Low-Dosage Hydrate Inhibitors (LDHIs) Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Low-Dosage Hydrate Inhibitors (LDHIs) Sales Market Share by Type in 2019
Figure 32. United States Low-Dosage Hydrate Inhibitors (LDHIs) Sales Market Share by Type in 2019
Figure 33. Europe Low-Dosage Hydrate Inhibitors (LDHIs) Sales Market Share by Company in 2019
Figure 34. Europe Low-Dosage Hydrate Inhibitors (LDHIs) Sales Market Share by Type in 2019
Figure 35. Europe Low-Dosage Hydrate Inhibitors (LDHIs) Sales Market Share by Application in 2019
Figure 36. China Low-Dosage Hydrate Inhibitors (LDHIs) Sales Market Share by Company in 2019
Figure 37. China Low-Dosage Hydrate Inhibitors (LDHIs) Sales Market Share by Type in 2019
Figure 38. China Low-Dosage Hydrate Inhibitors (LDHIs) Sales Market Share by Application in 2019
Figure 39. Japan Low-Dosage Hydrate Inhibitors (LDHIs) Sales Market Share by Company in 2019
Figure 40. Japan Low-Dosage Hydrate Inhibitors (LDHIs) Sales Market Share by Type in 2019
Figure 41. Japan Low-Dosage Hydrate Inhibitors (LDHIs) Sales Market Share by Application in 2019
Figure 42. Southeast Asia Low-Dosage Hydrate Inhibitors (LDHIs) Sales Market Share by Company in 2019
Figure 43. Southeast Asia Low-Dosage Hydrate Inhibitors (LDHIs) Sales Market Share by Type in 2019
Figure 44. Southeast Asia Low-Dosage Hydrate Inhibitors (LDHIs) Sales Market Share by Application in 2019
Figure 45. India Low-Dosage Hydrate Inhibitors (LDHIs) Sales Market Share by Company in 2019
Figure 46. India Low-Dosage Hydrate Inhibitors (LDHIs) Sales Market Share by Type in 2019
Figure 47. India Low-Dosage Hydrate Inhibitors (LDHIs) Sales Market Share by Application in 2019
Figure 48. Schlumberger Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. BHGE Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Halliburton Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Ecolab Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. BASF Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Arkema Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Ashland Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Clariant Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Key Raw Materials Price Trend
Figure 57. Manufacturing Cost Structure of Low-Dosage Hydrate Inhibitors (LDHIs)
Figure 58. Manufacturing Process Analysis of Low-Dosage Hydrate Inhibitors (LDHIs)
Figure 59. Low-Dosage Hydrate Inhibitors (LDHIs) Industrial Chain Analysis
Figure 60. Channels of Distribution
Figure 61. Distributors Profiles
Figure 62. Porter's Five Forces Analysis
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed

---